PINAR, İbrahim Ethem; OZKOCAMAN, Vildan. Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma. The European Research Journal, [S. l.], v. 9, n. 6, p. 1483–1492, 2023. DOI: 10.18621/eurj.1359362. Disponível em: https://eurj.org.tr/article/view/874. Acesso em: 5 apr. 2026.